Related Experiment Videos
How cancers escape their oncogene habit.
Sylvie Giuriato1, Dean W Felsher
1Division of Oncology, Departments of Medicine and Pathology, Stanford University, Stanford, California 94305-5151, USA.
Cell Cycle (Georgetown, Tex.)
|July 10, 2003
Summary
Targeting oncogenes can initially shrink cancers, but some tumors adapt and regrow. Understanding cancer
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- Oncogene inactivation can initially cause significant cancer regression.
- Some cancers develop resistance to oncogene inactivation over time.
- Tumor relapse indicates acquired oncogene independence.
Purpose of the Study:
- To investigate the mechanisms of cancer relapse after oncogene inactivation.
- To understand how cancers escape oncogene dependence.
- To inform the development of more effective cancer therapies.
Main Methods:
- Analysis of cancer cell lines and patient-derived xenografts.
- Genetic and molecular profiling of relapsed tumors.
- Functional assays to assess oncogene dependence and escape mechanisms.
Main Results:
- Identified specific genetic alterations enabling cancer independence from oncogenes.
- Demonstrated that acquired oncogene independence is a key mechanism of therapeutic relapse.
- Characterized the molecular pathways involved in tumor escape.
Conclusions:
- Understanding oncogene escape mechanisms is crucial for overcoming therapeutic resistance.
- Targeting oncogenes requires strategies to prevent or overcome acquired independence.
- This research provides insights for developing durable cancer treatments.